Bausch Health
BHC
#3584
Rank
HK$23.51 B
Marketcap
HK$63.66
Share price
-0.12%
Change (1 day)
18.24%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -HK$20.80

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -HK$20.68. In 2022 the company made an earnings per share (EPS) of -HK$4.83 an increase over its 2021 EPS that were of -HK$20.69.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$20.80330.34%
2022-HK$4.83-76.64%
2021-HK$20.6968.45%
2020-HK$12.28-68.91%
2019-HK$39.50-57.11%
2018-HK$92.10-272.22%
2017HK$53.48-199.29%
2016-HK$53.86798.7%
2015-HK$5.99-128.31%
2014HK$21.17-204.62%
2013-HK$20.24602.7%
2012-HK$2.88-171.15%
2011HK$4.05-143.96%
2010-HK$9.21-206.57%
2009HK$8.64-11.2%
2008HK$9.732.46%
2007HK$9.50-7.58%
2006HK$10.27-14.29%
2005HK$11.9954%
2004HK$7.78-500%
2003-HK$1.95-141.67%
2002HK$4.67-4.76%
2001HK$4.90-175%
2000-HK$6.54-268%
1999HK$3.8914.94%
1998HK$3.3920.83%
1997HK$2.8053.83%
1996HK$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$7.78-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.10-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA